| Customization: | Available |
|---|---|
| Application: | Internal Medicine |
| Usage Mode: | Injection |
|
Still deciding? Get samples of US$ 10/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
INDICATIONS
Second-line treatment drugs for pulmonary tuberculosis who have failed first-line anti-tuberculosis drugs (such as streptomycin, isoniazid, rifampicin, and ethambutol), or have toxic effects on one or more of the above drugs Or when bacteria are resistant, this product can be used as one of the combination drugs.
Adverse reactions
1. This product has significant nephrotoxicity, manifested as increased creatinine, blood urea nitrogen, decreased creatinine clearance, proteinuria, cast urine, etc. Renal function and urine routine should be monitored during medication.
2. There is damage to the 8th cranial nerve. Generally, vestibular function damage occurs when the drug is used to 2 to 4 months, while auditory damage is less.
3. There is a certain neuromuscular blocking effect.
4. Allergic reactions such as rash, itching, redness and swelling of the skin.
| Support OEM/ODM |
Yes |
| Standard Available |
CP,BP |
| Documents |
GMP,COPP,FSC,CTD |
){kind=link}